S100A9 and neoplasm: It was preclinically demonstrated that endogenous type I IFNs regulated the cellular composition within the PMN by restricting migration of neutrophils and therefore reduced the expression of pro-metastatic molecules such as S100A8, S100A9, Bv8 and MMP9 and inhibited extravasation efficiency of tumour cells [280].